Long noncoding RNAs (lncRNAs) are emerging as important regulators of tissue physiology and disease processes including cancer. To delineate genome-wide lncRNA expression, we curated 7,256 RNA sequencing (RNA-seq) libraries from tumors, normal tissues and cell lines comprising over 43 Tb of sequence from 25 independent studies. We applied ab initio assembly methodology to this data set, yielding a consensus human transcriptome of 91,013 expressed genes. Over 68% (58,648) of genes were classified as lncRNAs, of which 79% were previously unannotated. About 1% (597) of the lncRNAs harbored ultraconserved elements, and 7% (3,900) overlapped disease-associated SNPs. To prioritize lineage-specific, disease-associated lncRNA expression, we employed non-parametric differential expression testing and nominated 7,942 lineage- or cancer-associated lncRNA genes. The lncRNA landscape characterized here may shed light on normal biology and cancer pathogenesis and may be valuable for future biomarker development.
Cancers are a leading cause of morbidity and mortality worldwide, with over 14 million new cases and 8 million deaths in 2012 (ref. 1) . To improve understanding of cancer pathogenesis, ongoing largescale efforts led by The Cancer Genome Atlas (TCGA) are using high-throughput molecular profiling strategies to characterize genetic, epigenetic and transcriptional changes 2, 3 . However, efforts to interpret these data have mainly focused on protein-coding genes, despite definitive evidence that transcription of the noncoding genome produces functional RNAs 4 . In particular, lncRNAs have been implicated in biological, developmental and pathological processes and act through mechanisms such as chromatin reprogramming, cis regulation at enhancers and post-transcriptional regulation of mRNA processing 5, 6 .
The emergence of high-throughput RNA-seq technology provides a revolutionary means for the systematic discovery of transcriptional units. Indeed, RNA-seq has led to a deeper appreciation of the intricate nature of transcription by identifying a milieu of lncRNAs, both located in intergenic 'gene deserts' and overlapping proteincoding loci 4 . The aligned sequence data generated by RNA-seq experiments can be used to predict full-length transcripts in silico with ab initio transcriptome assembly 7, 8 . Ab initio assembly provides an unbiased modality for gene discovery and has been successful in pinpointing new cancer-associated lncRNAs 9 . Despite such efforts to catalog human lncRNAs, several lines of evidence suggest that the current knowledge of lncRNAs remains inadequate. First, reported discrepancies between independent lncRNA cataloguing efforts suggest that lncRNA annotations are fragmented or incomplete 10 . Second, previous studies largely avoided the annotation of monoexonic transcripts and intragenic lncRNAs owing to the added complexity of transcriptional reconstruction in these regions 11 . Third, the rapid coevolution of high-throughput sequencing technologies and bioinformatics algorithms now enables more accurate transcript reconstruction than was possible with previous efforts 8 . Fourth, high-throughput cataloguing efforts have thus far been confined to select cell lines, individual cancer types or relatively small cohorts 4, 9, 11 . However, cancers possess highly heterogeneous gene expression patterns, and detecting recurrent expression of subtype-specific lncRNAs will likely require the analysis of much larger tumor cohorts. Here we used a compendium of 7,256 RNA-seq libraries to comprehensively interrogate the human transcriptome, identifying 58,648 lncRNA genes. Moreover, we leveraged our data set to identify a myriad of lncRNAs associated with 27 tissue and cancer types. By uncovering this expansive landscape of tissue-and cancer-associated lncRNAs, we provide the scientific community with a powerful starting point to begin investigating their biological relevance.
The landscape of long noncoding RNAs in the human transcriptome from metastases and 701 originated from normal or benign, tumoradjacent tissues (Supplementary Fig. 1e ). We subsequently refer to this set of samples as the MiTranscriptome compendium.
To permit sensitive detection of lineage-specific transcription, we partitioned the libraries into 18 cohorts by organ system (Fig. 1a and Supplementary Table 2 ) and performed cohort-wise filtering and meta-assembly, before again merging the data (Fig. 1b) . We developed and employed computational methods to filter out libraryspecific background noise and predict the most likely isoforms from the assemblies of transcript fragments (transfrags) (Fig. 1b) . Our filtering approach used transcript abundance and recurrence information to differentiate robust transcription from incompletely processed RNA or contamination from genomic DNA 4 (Online Methods). This stringent approach eliminated the vast majority (>96%) of unannotated transfrags in the compendium (Online Methods and Supplementary  Fig. 2a-f) . The remaining transfrags were collapsed into full-length transcript predictions using a greedy dynamic programming algorithm (Online Methods and Supplementary Fig. 3a,b) . For example, in the chromosome 12 locus containing HOTAIR and HOXC11, the algorithm consolidated 7,471 raw transfrags into 17 transcripts, including ones that accurately matched annotated HOTAIR and HOXC11 isoforms (Supplementary Fig. 3c ). After merging the meta-assemblies from 18 cohorts for organ systems, we established a consensus set of 384,066 predicted transcripts that we designated as the MiTranscriptome assembly (Fig. 1b) .
To characterize the MiTranscriptome, we compared it to reference catalogs from RefSeq (December 2013) 12 , UCSC (December 2013) 13 and GENCODE (release 19) 10 and to intergenic lncRNA predictions from the previous cataloguing study by Cabili et al. 11 . We observed increases in the numbers of exons, splice sites, transcripts and genes Brain (398) Head and neck (334)
Thyroid (525) Lung ( npg a n a ly s i s of 29%, 52%, 95% and 57%, respectively, relative to GENCODE, the largest of the reference catalogs ( Fig. 1c and Online Methods). In terms of well-annotated genes, the assembly demonstrated high sensitivity at the nucleotide and splice-site levels, recovering 94% and 93% of RefSeq nucleotides and splice sites, respectively ( Supplementary  Fig. 4a,b) . However, detection of precise RefSeq splicing patterns, an ongoing challenge for in silico transcriptome reconstruction methods 8 , was just 31%. Unannotated transcripts were defined as those lacking strand-specific nucleotide overlap with reference transcripts (RefSeq, UCSC and GENCODE). Although the fraction of transcripts overlapping annotated genes was high in individual cohorts (range of 62-88%, mean of 75%), the fraction of annotated genes within the entire MiTranscriptome was just 46%, alluding to the presence of much unannotated transcription unique to specific lineages ( Supplementary Fig. 4c ).
To assess the robustness of the MiTranscriptome, we stratified transcripts into confidence tiers on the basis of annotation status, the presence of annotated splice junctions, and mono-or multiexonic structure (Supplementary Table 4 ). Using the empirical cumulative distribution function derived from annotated transcript expression levels, we assigned confidence scores to unannotated transcripts ( Supplementary  Fig. 5a ). Next, we performed quantitative RT-PCR (qRT-PCR) validations of 100 unannotated transcripts (38 monoexonic and 62 multiexonic) with modest expression (fragments per kilobase of exon per million fragments mapped (FPKM) > 1.0) in at least one of the lung (A549), prostate (LNCaP) and breast (MCF-7) cancer cell lines (Online Methods). To assess false positives arising from background levels of genomic DNA, we also included control reactions without reverse transcriptase. Of the 100 lncRNAs tested, 95 had significantly higher expression in the appropriate cell line than the control (Student's t test, P < 0.05; Supplementary Fig. 6 ) and showed high correlation between qRT-PCR and RNA-seq expression profiles (Supplementary Fig. 7a ). In addition, we also performed independent Sanger sequence verification of 18 amplicons that were highly expressed in the 3 cell lines (Supplementary Fig. 7b ,c and Supplementary Table 5 ).
Coding potential assessment of long RNA transcripts
To facilitate further study of the assembly, we classified transcripts into one of five categories: (i) protein coding, (ii) read-through (implying a transcript overlapping multiple separate annotated genes), (iii) pseudogene, (iv) lncRNA and (v) transcript of unknown coding potential (TUCP) (Supplementary Fig. 8a ). The TUCP classification was originally suggested by Cabili et al. 11 and pertains to long RNAs with in silico evidence of coding potential. The ability to predict coding potential from sequence features alone has important implications for ab initio transcript annotation studies (Supplementary Note). Here we predicted TUCPs by incorporating two methods: (i) predictions from the Coding Potential Assessment Tool (CPAT) 14 , which analyzes the sequence features of transcript ORFs, and (ii) screening Remarkably, over 60% of MiTranscriptome genes were classified as either lncRNAs or TUCPs (59% lncRNAs and 3.5% TUCPs; Fig. 2a) . The majority of lncRNAs and TUCPs were unannotated relative to RefSeq, UCSC and GENCODE genes (79% and 66%, respectively) and were located within intergenic regions (72% and 60%, respectively) (Fig. 2b) . Interestingly, 5,248 transcripts overlapping annotated lncRNAs were flagged as TUCPs, suggesting that previous annotation attempts identified ostensibly noncoding fragments of transcripts possessing robust ORFs. For example, in a chromosome 16 intergenic locus, we detected transcripts harboring an ORF, predicted to encode a 418-amino-acid product, containing 29 exons that overlapped 3 independent genes annotated by GENCODE as lncRNAs (LINC00514, LA16c-380H5.3 and LA16c-380H5.4), suggesting that some annotated lncRNAs might in fact be inaccurate partial representations of a larger protein-coding gene (Fig. 2c) . To further investigate coding potential, we searched a large human proteomics data set derived from benign tissue samples 16 for peptides uniquely mapping to TUCP ORFs and noted 268 such genes (Supplementary Table 6 ). Given these intriguing results, we anticipate that future integration of proteomics data from tumor tissues will strengthen our TUCP predictions.
Characterization of long RNAs
lncRNA and TUCP genes tended to have fewer exons than read-through or protein-coding genes, but we nevertheless observed appreciable alternative splicing for all classes of transcripts 11, 17 ( Supplementary  Fig. 5b ). Furthermore, we observed that lncRNAs and TUCPs were expressed at lower levels than read-through or protein-coding transcripts, which is consistent with previous studies 9, 11, 17, 18 (Fig. 2d) . To further corroborate active transcription of the lncRNAs and TUCPs, we intersected intervals surrounding the transcription start sites (TSSs) with ENCODE chromatin immunoprecipitation and sequencing (ChIP-seq) data for histone 3 lysine 4 trimethylation (H3K4me3), RNA polymerase II (Pol II) binding sites and DNase I hypersensitivity data from 13 cell lines 19, 20 (Online Methods). Maximal enrichment of these marks at the TSSs of these genes but not at randomly shuffled npg a n a ly s i s control regions suggests that the assembled lncRNA and TUCP transcripts possess actively regulated promoters ( Fig. 2e-g ).
lncRNAs harboring conserved elements
The evolutionary conservation of lncRNAs has been a topic of ongoing conversation, with several reports suggesting that lncRNAs are modestly conserved 11, 17, 18, 21 . In agreement with previous reports, we observed increases in both transcript and promoter conservation levels for lncRNAs and TUCPs relative to random control regions (Online Methods and Supplementary Fig. 5c-f) . Shifts in the cumulative distributions of lncRNA and TUCP transcripts were greater for annotated transcripts than for unannotated transcripts. This difference might reflect discovery bias toward highly conserved genes detectable across multiple model systems. Moreover, the subtle increases in conservation we observe for lncRNAs suggest, at least in humans, that lncRNA conservation might be an exceptional phenomenon rather than a general one. Therefore, we specifically delineated 3,309 lncRNAs (5.6% of all lncRNAs) harboring markedly higher base-wise conservation than random intergenic regions to enable the focused study of these transcripts (Fig. 3a , Online Methods and Supplementary Fig. 5e ). In addition, an intriguing aspect of the noncoding genome includes ultraconserved elements (UCEs), which are stretches of DNA >200 nt in length with nearly perfect sequence identity across multiple organisms 22, 23 . We delineated 597 intergenic lncRNAs (1.2% of all intergenic lncRNAs) harboring UCEs and designated these as highly conserved long intergenic noncoding RNAs (HICLINCs) (Online Methods and Supplementary Fig. 5h ). For example, THCAT126, a previously unannotated intergenic lncRNA on chromosome 2q24, contains elements in its final exons that are conserved in nearly all vertebrates including zebrafish (Fig. 3b) . Moreover, THCAT126 is expressed widely across many tissue types, including thyroid cancer (Fig. 3c) . Highly conserved lncRNAs such as THCAT126 (and other cancer-associated HICLINCs described below) provide an exciting avenue for in vivo study of the role of lncRNAs in development and carcinogenesis.
lncRNAs overlapping disease-associated SNPs
To investigate the relationship of the MiTranscriptome assembly with disease-associated regions of the genome, we assessed the overlap of transcripts in the assembly with 11,194 unique disease-associated SNPs from a catalog of genome-wide association studies (GWAS) 24 . MiTranscriptome exons and transcripts overlapped 2,586 and 9,770 GWAS SNPs in comparison to just 1,096 and 7,050 SNPs overlapped by reference transcripts, respectively ( Supplementary Fig. 9a,b) . Altogether, transcripts in the assembly overlapped 2,881 formerly intergenic SNPs located within gene deserts and only lacked 161 GWAS SNPs overlapping annotated genes. We tested for the possibility that the increased overlap with GWAS SNPs occurred at a rate above chance and observed that both MiTranscriptome transcripts and exons were significantly enriched for GWAS SNPs relative to random SNPs chosen from the same chip platform (paired t test, P = 5.25 × 10 −135 and 1.15 × 10 −199 , respectively; Online Methods, Supplementary Fig. 9c and Supplementary Note). Moreover, unannotated intergenic lncRNAs and TUCPs were also significantly enriched for diseaseassociated regions, with exons more highly enriched than full-length transcripts (paired t test, P = 9.90 × 10 −78 and 5.50 × 10 −50 for whole transcripts and exons, respectively; Supplementary Fig. 9d ). These data argue that a rigorous reevaluation of the regulation of allelespecific gene expression in regions proximal to GWAS SNPs might yield informative biological associations with the new lncRNAs identified in this study.
Differential expression analysis
Our large-scale transcriptome reconstruction process unveiled tremendous transcriptional complexity highlighted by the presence of thousands of uncharacterized lncRNAs and TUCPs. To prioritize disease-associated and lineage-specific transcription, we developed a non-parametric method for the testing of differential expression called Sample Set Enrichment Analysis (SSEA) (Online Methods and Supplementary Note). SSEA adapts the weighted KolmorgorovSmirnoff-like tests used by Gene Set Enrichment Analysis (GSEA) 25 to discover transcript expression changes between two groups of samples. The non-parametric nature of this method permits sensitive detection of differential expression within heterogeneous sample populations (for example, tumor subtypes). We performed 50 analyses of differential expression including various cancer or normal lineage types (one cancer or lineage type versus all other MiTranscriptome samples) and cancer versus normal comparisons within a single tissue type ( Fig. 4a and Online Methods). Collectively, SSEA detected over 2 million significant associations (false discovery rate (FDR) < 1 × 10 −3 for cancer versus normal analyses and FDR < 1 × 10 −7 for lineage analyses) involving 267,726 MiTranscriptome transcripts (Online Methods and Supplementary Table 7) . To validate the enrichment testing approach, we assessed its ability to rediscover known biomarkers upregulated and downregulated in prostate and breast cancers. We assessed the concordance between the top 1% of positively and negatively enriched genes from each cancer type with cancer gene signatures obtained from the Oncomine database of microarray studies [26] [27] [28] [29] [30] [31] [32] (Online Methods  and Supplementary Table 8) . A heat map of the odds ratios of the gene signature associations showed striking agreement between SSEA and the other studies, with SSEA often demonstrating equal or better concordance to each microarray study than comparison between microarray studies ( Fig. 4b and Supplementary Table 9) . Thus, testing for isoform-level differential expression from the MiTranscriptome ab initio assembly of RNA-seq data recapitulated the results from cancer microarray gene expression studies, supporting the SSEA method as a viable tool for the detection of differential expression.
To further credential the enrichment testing approach, we assessed its ability to detect positive control lncRNAs and protein-coding genes in breast and prostate cancers. For example, SSEA correctly identified the oncogenic lncRNA HOTAIR, ESR1 (encoding estrogen receptor 1) and GATA3 (encoding GATA-binding protein 3) as highly positively enriched in breast cancers and accurately nominated the tumorsuppressor lncRNA MEG3 and the metastasis-suppressor LIFR 33 as highly negatively enriched 30, 31, 34, 35 (Fig. 4c-e) . Similarly, in prostate cancers, SSEA detected differential expression of lncRNAs and protein-coding genes consistent with the literature (Fig. 4f) . Notably, the known prostate cancer lncRNAs PCA3 (prostate cancer antigen-3) and SChLAP1 were strikingly enriched in a cancer-specific and prostate-specific manner relative to all other sample set analyses (Fig. 4g,h) 28, 36 . Overall, the ability of the enrichment testing approach to rediscover known cancer-associated genes in an unbiased fashion indicates its usefulness for the analysis of cancer association and lineage specificity within the panorama of uncharacterized transcription unveiled by MiTranscriptome.
Characterization of differentially expressed lncRNAs
To extend our study beyond known cancer-associated genes, we mined the enrichment test results for lineage-specific and cancerspecific transcripts in an unbiased manner. Lineage specificity was assayed using sample sets for each cancer or tissue type in comparison to all other samples in the MiTranscriptome compendium (Fig. 4a , "Cancer types" and "Normal types"), and SSEA results were used npg a n a ly s i s Supplementary Fig. 10a) npg a n a ly s i s myeloid leukemia (CML) and myeloproliferative neoplasia (MPN)), brain cancers (low-grade glioma (LGG) and glioblastoma multiforme (GBM)) and muscle tissue (cardiac and skeletal). Additionally, a cluster comprising cervical cancer, head and neck cancer and normal lineages, lung squamous cell cancer and bladder cancer emerged, suggesting that primarily squamous (and transitional) cell carcinomas from distant primary sites share important gene expression relationships. Intriguingly, unsupervised clustering of only the lncRNAs in the top 1% of the SSEA analysis for lineage association recapitulated all of these relationships, indicating the capacity for lncRNAs to independently identify cancer and normal lineages (Fig. 5a) . Next, we investigated the dimension of cancer-specific transcriptional dynamics in 12 tissues with ample numbers of both cancer and normal samples (Fig. 4a, "Cancer versus normal" ). Similar to above, unsupervised clustering of the top 1% of cancer-associated lncRNAs demonstrated highly specific signatures for each cancer type, with the exception of lung and kidney cancers ( Fig. 5b and Supplementary  Fig. 10b ). Lung squamous cell carcinomas (LUSC) and adenocarcinomas (LUAD) clustered together and shared numerous transcripts with cancer association. Similarly, renal clear cell (KIRC) and papillary cell (KIRP) carcinomas exhibited highly overlapping signatures, whereas renal chromophobe carcinomas (KICH) remained distinct from KIRC and KIRP.
Finally, we intersected the results from the lineage and cancer analyses. With extensive further evaluation, such transcripts might have translational potential for use in non-invasive clinical tests, particularly for cancers that lack reliable biomarkers. Notable examples included the prostate-specific lncRNAs PCA3 and SChLAP1 presented earlier (Fig. 4g,h) . A myriad of lncRNAs were detected as being lineage and cancer associated (in the top 5% of both analyses) for each of the cancer types analyzed (Fig. 5c and Supplementary Fig. 11a) . A direct comparison of lncRNAs and protein-coding transcripts showed that both annotated and unannotated lncRNAs have the potential to perform at a comparable level to protein-coding genes, supporting a role for lncRNAs in augmenting tissue-and cancerspecific gene signatures ( Fig. 5d and Supplementary Fig. 11b,c) .
We applied stringent statistical cutoffs to nominate 7,942 lncRNA or TUCP genes (11,478 transcripts) as cancer associated, lineage associated or both (Online Methods and Supplementary Table 10) . Transcripts meeting the stringent cutoffs in the cancer versus normal analyses were designated as having cancer association. Those transcripts meeting stringent cutoffs for lineage specificity in noncancerous tissue (for example, heart, skeletal muscle or embryonic stem cells) and in cancers lacking RNA-seq data for benign tissue were designated as lineage associated. Moreover, transcripts meeting the cutoffs for both the cancer versus normal and lineage specificity analyses were designated as having cancer and lineage association ( Table 1) . Transcripts with significant association in just one tissue type were given names according to that tissue type ( Table 1) , and transcripts with associations in multiple tissues were named cancerassociated transcripts (CATs). An additional 545 lncRNA genes (1,634 transcripts) that possessed UCEs but did not meet the stringent npg a n a ly s i s lineage and cancer association criteria were designated as HICLINCs. Of these 8,487 lncRNAs, 7,804 did not possess an official gene symbol according to the Human Genome Organization (HUGO) Gene Nomenclature Committee 33 and were thus named according to the convention described in Table 1 .
To infer putative roles for cancer-or lineage-associated lncRNAs in oncogenesis, we curated 2,078 MSigDB gene sets into categories corresponding to biological function (angiogenesis and hypoxia, metastasis, proliferation and cell cycle, cell adhesion, and DNA damage and repair) or signatures from gene expression profiling studies (Supplementary Table 11) 25 . We constructed an expression correlation matrix between lncRNAs and protein-coding genes and employed a 'guilt-by-association' analysis whereby the correlation data were processed by GSEA to generate a matrix of the association of each lncRNA with each gene set, capturing over 14,000 transcripts with significant associations (family-wise error rate (FWER) < 0.001; Online Methods and Supplementary Tables 12 and 13) 37 .
To allow the scientific community to explore our discoveries, we developed an online portal featuring detailed characteristics of the nominated transcripts (see URLs) and present several examples of intriguing lncRNAs here. First, BRCAT49 (breast cancer-associated transcript-49) is a breast cancer-and lineage-associated lncRNA gene (Fig. 5d ) located ~45 kb downstream of the intergenic breast cancer-associated SNP rs13387042 that has been implicated by multiple GWAS (Fig. 5e,f) [38] [39] [40] [41] [42] . BRCAT49 provides a possible target for explaining the breast cancer association of this genomic region and would be a candidate for intergenic expression quantitative trait locus (eQTL) analysis. We also performed further interrogation of the relationship with GWAS SNPs, and all transcripts within 50 kb of a GWAS SNP implicated in a disease locus for which the lncRNA was identified as having a significant association are reported in Supplementary  Table 14 . Second, the lncRNA gene we termed MEAT6 (melanomaassociated transcript-6) was found to be in the 99.8th percentile in the melanoma lineage SSEA analysis (Fig. 5a) . Genomic investigation delineated MEAT6 as a partially annotated transcriptional variant of the lncRNA AK090788 on chromosome 6q26 (Supplementary Fig. 12a ). However, MEAT6 uses an alternative start site and upstream exons absent from reference catalogs. Expression of MEAT6 isoforms using the novel start site was highly specific to the melanoma samples in the MiTranscriptome cohort (Fig. 5g) ; in contrast, isoforms lacking the MEAT6 start site had a dramatically different pan-cancer expression profile with almost no expression in melanoma ( Supplementary  Fig. 12b) . Additional examples of expression profiles for canceror lineage-specific lncRNAs in other tissue types are displayed in Supplementary Figure 12c,d . The examples shown here are indeed representative, and we anticipate that an abundance of uncharacterized transcription with biological and translational potential can be leveraged using our discoveries here and our online resource (see URLs; Supplementary Tables 10 and 11).
DISCUSSION
Here we discovered and characterized an expanded landscape of transcription via unbiased transcriptome reconstruction from thousands of tumors, normal tissues and cell lines. Our work uses several orders of magnitude more RNA-seq data (~100-fold) than previous RNA-seq lncRNA discovery efforts and vastly increases the universe of known transcripts in both normal tissues and cancer. The unprecedented breadth (6,503 samples) and depth (>43 Tb of sequence) of our compendium enabled the sensitive detection of robust transcription and the specific filtering out of background noise. The lncRNAs in our assembly (58,648 genes, often with multiple isoforms) far outnumber entries in current lncRNA databases (<16,000 genes), implying that reference transcript annotations might be fragmented or otherwise incomplete 11, 17, [43] [44] [45] [46] . Moreover, our assembly indicates that the genomic diversity of lncRNAs eclipses that of coding transcripts (with nearly 60,000 lncRNA genes versus approximately 30,000 protein-coding genes), a disparity that may grow as additional diseases and cell types are sequenced and more lncRNAs are discovered.
Multiple lines of in silico evidence support the biological and functional relevance of MiTranscriptome transcripts, including robust expression, protein-coding potential (for TUCPs), high conservation, active regulation at promoters, proximity to diseaseassociated genomic polymorphisms, correlation with protein-coding gene signatures, lineage specificity and cancer specificity. Moreover, many lncRNAs independently identified by this study have previously been validated and mechanistically linked to carcinogenesis (Supplementary Table 15 ) 35, 36, [47] [48] [49] . Regardless of their functional contributions, uncharacterized MiTranscriptome transcripts could serve as future cancer biomarkers.
Although the central dogma remains a core tenet of cellular and molecular biology, the appreciation of lncRNAs as functional genomic elements that defy the central dogma may be essential for fully understanding biology and disease. Taken together, our results indicate that the vastness and complexity of lncRNA transcription has been grossly underappreciated and that a myriad of lncRNAs are associated with carcinogenesis. We anticipate that the MiTranscriptome assembly and lncRNAs identified by this study, as well as the computational tools developed herein, will provide a foundation for lncRNA genomics, biomarker development and the delineation of cancer disease mechanisms.
URLs. MiTranscriptome Online Portal, http://mitranscriptome.org/.
METhODS
Methods and any associated references are available in the online version of the paper. 
ONLINE METhODS
High-performance computing. Computational analysis was performed using the Flux high-performance computer cluster hosted by Advanced Research Computing (ARC) at the University of Michigan.
RNA sequencing data processing. A comprehensive RNA-seq analysis pipeline was employed on all samples (Supplementary Fig. 1b) . The analysis pipeline provided sequence quality metrics, filtering of contaminant reads, fragment size estimation, strand-specific library type estimation, spliced alignment of reads to the human reference genome (version hg19/GRCh37), alignment performance metrics, generation of visualization tracks for genome browsers and ab initio transcript assembly. The third-party tools used to process the RNA-seq data were selected on the basis of computational performance, ease of use, user and community support, and experience (Supplementary Table 3 ). Further details are described in the Supplementary Note.
Overview of transcriptome reconstruction. To merge the ab initio-assembled transcript fragments (transfrags) into a consensus transcriptome, we developed and used a bioinformatics method that (i) classifies and filters out sources of background noise in individual libraries and (ii) reassembles transfrags weighted by their expression levels from multiple libraries into a consensus transcriptome. More details are provided in the Supplementary Note. Filtration of noise contamination. We controlled for alignment artifacts and poorly assembled transcripts by clipping very short first or last exons (<15 bp) and excluding short transfrags (≤250 bp). We removed noise due to genomic DNA contamination and incompletely processed RNA using a machine learning method. The method models the empirical distributions of relative transcript abundance and recurrence (number of independent samples in which the transcript was observed). From this model, the method determines the optimal library-specific thresholds for distinguishing annotated from unannotated transcription as a proxy for signal versus background noise, respectively. Further details are described in the Supplementary Note.
Transcriptome meta-assembly. We created directed acyclic splicing graphs where nodes in the graph reflected contiguous exonic regions and edges corresponded to splicing possibilities (Supplementary Fig. 3a) . Nodes in the splicing graph with relatively low abundance were then pruned. We then incorporated the partial path information inherent for transfrags spanning multiple exons by building splicing pattern graphs that subsumed the original splice graphs (Supplementary Fig. 3b) . The splicing pattern graph is a type of de Bruijn graph where each node represents a contiguous path of length k through the splice graph and edges connect paths with k -1 nodes in common. The algorithm finds and reports a set of highly abundant transcripts by iteratively traversing the graph using dynamic programming in a greedy fashion. Further details are described in the Supplementary Note.
Merging of meta-assemblies. To merge the meta-assemblies from 18 cohorts, we used the Cuffmerge tool 50 , which produced a final transcriptome GTF file.
Comparisons of MiTranscriptome with reference catalogs. The exons, splice sites and splicing patterns of all assembled transcripts were compared to RefSeq, UCSC, GENCODE (version 19) and the merged union of all three reference catalogs using custom Python scripts. Sensitivity and precision values were computed using the number of shared strand-specific transcribed bases, introns and splicing patterns. Precision was also computed for the subset of ab initio transcripts that overlapped any part of a reference transcript. Transcripts that overlapped a reference transcript on the same strand were designated as annotated. When an ab initio transcript matched multiple reference transcripts, a best match was chosen using the following criteria: (i) matching splicing patterns, (ii) fraction of shared introns and (iii) fraction of shared transcribed bases. The biotype (protein, read-through, pseudogene or lncRNA) for the annotated transcripts was imputed from the best match reference transcript. Annotated lncRNAs and unannotated transcripts were reclassified as either lncRNAs or TUCPs.
Prediction of transcripts of unknown coding potential. We predicted coding potential by integrating two sources of evidence: (i) predictions from the alignment-free Coding Potential Assessment Tool (CPAT) 14 and (ii) searches for Pfam 27.0 matches 15 . CPAT determines the coding probability of transcript sequences using a logistic regression model built from ORF size, Fickett TESTCODE statistic 51 and hexamer usage bias. We chose a CPAT probability cutoff by repeatedly randomly sampling 100,000 each of putative noncoding and protein-coding transcripts and optimizing on the balanced accuracy metric (average of sensitivity and specificity; Supplementary Fig. 8b,c) . The average area under the curve (AUC) across 100 iterations was 0.9310 (minimum = 0.9302, maximum = 0.9320), and the average optimal probability cutoff was 0.5242 (minimum = 0.5090, maximum = 0.5482). This cutoff value achieved accurate discrimination of lncRNAs and protein-coding genes (sensitivity = 0.84, specificity = 0.95, FDR = 0.076). Of the putative noncoding transcripts, 9,903 (5.3%) exceeded the CPAT cutoff and met the criteria for TUCPs. As additional evidence of coding potential, we scanned all transcripts for Pfam A or B domains across the three translated reading frames for stranded transcripts and the six reading frames for monoexonic transcripts of unknown strand (Supplementary Note). We designated putative noncoding transcripts with either a Pfam domain or a positive CPAT prediction as TUCPs.
Proteomics analysis. We obtained the following Thermo files (in the RAW format) from a recent study mapping the human proteome 52 : Adult_Kidney_ Gel_Elite_55, Adult_Liver_Gel_Elite_56, Adult_Pancreas_Gel_Elite_60, Adult_Rectum_Gel_Elite_63, Adult_Urinarybladder_Gel_Elite_40, Fetal_ Brain_Gel_Velos_16, Adult_Lung_Gel_Elite_56 and Adult_Prostate_Gel_ Elite_62. The Thermo files were transformed into mzXML using MSConverter 53 and interrogated against human UniProt database V.15.11 using the X!Tandem search engine. The database was concatenated with all possible ORFs longer than 7 amino acids from the lncRNAs and with reversed sequences for the determination of FDR values. The X!Tandem search parameters were as follows: fully tryptic cleavage, parent mass error 5 ppm, fragment mass error 0.5 Da, 2 allowed missed cleavages, fixed modifications: cysteine carbamidomethylation; variable modifications: methionine oxidation. X!Tandem output files were processed by PeptideProphet and ProteinProphet. Data were filtered at a peptide probability of 0.5 and a protein probability of 0.9 to ensure protein FDR < 1%.
Confidence scoring system. After assembly of the MiTranscriptome, transcripts were subjected to an additional confidence evaluation. lncRNAs in the MiTranscriptome were categorized into tiers on the basis of their annotation status and the degree of matching of splice junctions to the reference annotation (Supplementary Table 4) . Tier 1 transcripts are all annotated, and tier 2 transcripts are unannotated. An empirical cumulative distribution function (eCDF) was developed by profiling the second highest expression value (across all 6,503 samples) for each tier 1 transcript. The second highest value was used to control for outlier expression. The eCDF was used to compute confidence scores for tier 2 transcripts using the same expression summary statistic.
Validation of lncRNA transcripts by quantitative RT-PCR.
We chose 150 lncRNAs with at least 1 FPKM expression in either A549, LNCaP or MCF-7 cells for biological validation. For each transcript, primer pairs were designed using the Primer-BLAST tool 54 . Primer pairs with the following parameters were selected: (i) amplicon length of 80-140 bp, (ii) primer GC content of 35-65% and (iii) primer length greater than 20 bp. Primers were used for BLAST runs against the human genome to ensure specificity to our target gene, and primers designed against multiexonic transcripts spanned exon junctions. Regions of any transcript that directly overlapped an exon on the antisense strand were avoided. Primer pairs meeting these criteria could be designed for 100 of 150 lncRNAs (38 monoexonic and 62 multiexonic). All oligonucleotide primers were obtained from Integrated DNA Technologies, and their sequences are listed in Supplementary Table 5 .
RNA was isolated from A549, LNCaP and MCF-7 cells in TRIzol (Invitrogen) using the RNeasy Mini kit (Qiagen). An equal amount of RNA was converted npg to cDNA using random primers and the SuperScript III reverse transcription system (Invitrogen). qRT-PCR was performed using Power SYBR Green Mastermix (Applied Biosystems) on an Applied Biosystems 7900HT RealTime PCR System. The housekeeping genes CHMP2A, EMC7, GPI, PSMB2, PSMB4, RAB7A, REEP5 and SNRPD3 were used as loading controls 55 . Data were normalized first to the values for housekeeping genes and then to the median value for all samples using the ∆∆C t method and plotted as fold change over the median. To ensure the specificity of the primers, 20 amplicons were further analyzed by Sanger sequencing.
Cell lines and reagents. All cell lines were obtained from the American Type Culture Collection (ATCC). Cell lines were maintained using standard conditions. Specifically, A549 cells were grown in F-12K with 10% FBS, LNCaP cells were grown in RMPI-1640 (Invitrogen) with 10% FBS and 1% penicillin-streptomycin and MCF-7 cells were grown in Eagle's Minimum Essential Medium (EMEM) plus 10% FBS. All of the cell lines were grown in a cell culture incubator at 37 °C with 5% CO 2 . To ensure their identity, cell lines were genotyped at the University of Michigan Sequencing Core using Profiler Plus (Applied Biosystems) and compared with the short tandem repeat (STR) profiles of respective cell lines available in the STR Profile Database (ATCC). All of the cell lines were routinely tested and found to be free of Mycoplasma contamination.
Evidence for active regulation of transcriptional start sites. To conduct analysis of TSS intervals, ENCODE Project data sets were downloaded from the UCSC Genome Browser 13 . For H3K4me3 analysis, we used the ENCODE Project Broad Institute H3K4me3 ChIP-seq peaks for the GM12878, H1-hESC, HeLa-S3, HepG2, HMEC, HSMM, HSMMtube, HUVEC, K562, NH-A, NHDF-Ad, NHEK and NHLF cell lines 56 . For Pol II analysis we used POL2RA binding sites from the ENCODE Project Uniform TFBS master file version 3 for any of the cell lines with H3k4me3 data 19 . Finally, for the DNase I hypersensitivity analysis, the ENCODE Project combined University of Washington and Duke University DNase I hypersensitivity regions were downloaded as a master file from the European Molecular Biology Laboratory-European Bioinformatics Institute (EMBL-EBI) and filtered for any of the cell lines with H3k4me3 data. Peak enrichment files (BED format) were aggregated across all cell lines. Intervals of ±10 kb surrounding unique MiTranscriptome TSSs were generated using the BEDTools slop tool 57 . To control for expression, TSSs were filtered to remove transcripts not expressed in any of the cell lines (FPKM < 0.1). Base-wise peak coverage was generated for each TSS interval using the BEDTools coverage function and summarized across subsets of TSSs. Summed per-base coverage histograms were normalized by dividing by the number of expressed TSSs.
Conservation analysis.
The evolutionary conservation of transcripts in our assembly was studied using two metrics: (i) the fraction of significantly conserved bases (P ≤ 0.01, phyloP algorithm) and (ii) the maximally conserved 200-nt sliding window (phastCons scores averaged within each window). The former captures independently conserved elements within a transcript regardless of position, and the latter captures contiguous regions of high conservation. The 200-nt sliding window size was chosen to aid in the discovery of putative UCEs 23 . As a negative control, we measured the conservation of non-transcribed regions using these metrics by randomly sampling contiguous length-matched intervals from intergenic and intronic space. Non-transcribed interval sampling was restricted to regions with valid 46-way conservation data.
The fractional base-wise conservation and contiguous window conservation metrics were used to nominate highly conserved and ultraconserved transcripts, respectively. In both cases, cutoffs for significant transcripts were determined by controlling the rate of observing elements with similar conservation levels within non-transcribed intergenic space at a level of 0.01. For fractional base-wise conservation, a score of 0.0947 (9.5% of transcript bases conserved at phyloP P value < 0.01) corresponded to FDR < 0.01. At this cutoff, the sensitivity for detecting protein-coding transcripts was 0.67. For contiguous sliding window conservation, an average phastCons probability of 0.9986 corresponded to FDR < 0.01. At this cutoff, the sensitivity for detecting true positive ultraconserved noncoding elements downloaded from UCNEbase was 0.69 (ref. 22) . Applying these criteria to our assembly yielded 6,034 lncRNAs (3.4%) and 541 TUCPs (4.7%) with significant basewise conservation levels. Additionally, 1,686 lncRNAs (0.96%) and 121 TUCPs (0.01%) harbored contiguous ultraconserved regions.
GWAS analysis.
A list of GWAS SNPs was obtained from the National Human Genome Research Institute's GWAS catalog (accessed 6 January 2014) 24 . SNP haplotypes were excluded from the SNP overlap analysis, and a list of 11,194 unique SNPs was obtained. The merged union of the RefSeq, UCSC and GENCODE catalogs was used as a reference for comparison with MiTranscriptome. Please refer to the Supplementary Note for a description of the GWAS overlap enrichment testing analysis.
Transcript expression estimation. Expression levels (FPKM) of the transcripts in the assembly were determined using Cufflinks (versions 2.02 and 2.1.1) 58 . Normalized abundance estimates (FPKM) were computed for all MiTranscriptome transcripts, converted into approximate fragment count values and aggregated into a matrix of expression data ( Fig. 4a and Supplementary Note). Library size factors for expression normalization were computed by applying the geometric normalization method described by Anders and Huber 59 .
Transcript expression enrichment analysis.
To analyze the differential expression of transcripts relative to sample phenotypes, we developed a method called Sample Set Enrichment Analysis (SSEA). SSEA performs weighted KS tests using normalized count data vectors as weights. To convert count values into weights for a single KS test, the following steps are performed: (i) raw count values are normalized by library-specific size factors, (ii) normalized count values are 'resampled' from a Poisson distribution (where λ equals the observed count value) to mimic the effect of technical replication and (iii) random Poisson noise (by default, λ = 1) is added to the normalized, resampled count values to destabilize zero-valued counts and break ties. A power transform (exponential or logarithmic) is then applied to the weights (by default, a log transformation is applied after incrementing normalized count values by 1). The choice of power transformation influences the relative importance of precision versus recall during enrichment testing. For example, users aiming to discover genes new in molecular subtypes of a disease would prioritize precision over sensitivity, whereas a user aiming to discover ideal biomarkers might value sensitivity over precision. After count data normalization and power transformation, SSEA performs the weighted KS test procedure described in GSEA 25, 60 . The resulting enrichment score statistic describes the strength of the association between the weights and the sample set.
To control for random sampling bias in count values (for example, 'shot noise'), SSEA performs repeated enrichment tests using resampled count values to mimic observations from technical replicates and uses the median enrichment score (by default, 100 tests are performed). The basis for Poisson resampling as a legitimate model for technical replication was established by Marioni et al. 60 . To test for significance, SSEA performs enrichment tests using randomly shuffled sample labels to derive a set of null enrichment scores with the same sign as the observed score (by default, 1,000 null enrichment scores are computed). The nominal P value reported is the relative rank of the observed enrichment score within the null enrichment scores. To control for multiple-hypothesis testing, SSEA maintains the null normalized enrichment score (NES) distributions for all transcripts in a sample set and uses the null NES distribution to compute FDR q values in the same manner as proposed by Subramanian et al. 25 .
Benchmarking SSEA performance using microarray gene signatures. Gene signatures for the top 1% of overexpressed and underexpressed genes from three prostate cancer [26] [27] [28] and three breast cancer [29] [30] [31] microarray studies were obtained using Oncomine 32 (Supplementary Table 8) . The top 1% of gene signatures as detected by SSEA in the MiTranscriptome breast and prostate cohorts were determined using prostate cancer versus normal and breast cancer versus normal sample sets (Fig. 4a) . Given that the MiTranscriptome was produced from an ab initio assembly, transcript identity was assigned to the annotated reference gene with the greatest degree of concordance, where degree of splicing agreement was prioritized npg
